Results 11 to 20 of about 4,372,786 (304)

The seroepidemiology of human-papillomavirus in relation to non-melanoma skin cancer [PDF]

open access: yes, 2009
PhDNon-melanoma skin cancer, comprising basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) is the most commonly diagnosed cancer in Caucasian populations.
Casabonne, Delphine
core   +4 more sources

The UQ Flap: A Novel Modification of the Keystone Flap

open access: yesPlastic and Reconstructive Surgery, Global Open, 2022
Summary:. Wound closure following excisions on the leg (between the knee and ankle), including the distal leg, is challenged by limited skin laxity. The keystone flap, first described by Behan in 2003, was proposed as one solution, but with a significant
Mohammadreza Hassani, MD, MMed (Skin Cancer)   +5 more
doaj   +1 more source

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

open access: yesJournal for ImmunoTherapy of Cancer, 2019
Background Predicting metastasis in melanoma patients is important for disease management and could help to identify those who might benefit from adjuvant treatment.
Nikolaus B. Wagner   +17 more
doaj   +1 more source

A multifaceted perspective on skin cancer prevention [PDF]

open access: yes, 2015
Solar ultraviolet radiation has been acknowledged as the main culprit for the three major types of skin cancer which are among the most numerous (basal cell carcinoma [BCC], squamous cell carcinoma [SCC]) and most dangerous (cutaneous malignant ...
Reinau, Daphne
core   +1 more source

Resource provision and environmental change for the prevention of skin cancer: systematic review of qualitative evidence from high-income countries. [PDF]

open access: yes, 2012
This paper presents the findings of a systematic review of qualitative studies from high-income (OECD) countries relating to sun protection and skin cancer, with a focus on barriers and facilitators for the following interventions: resource provision ...
Jamal, Farah   +5 more
core   +1 more source

Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary results

open access: yesOncoImmunology, 2019
Background: Melanoma of unknown primary (MUP) is an uncommon clinical subtype of melanoma of known primary (MKP). Objectives: We aimed to compare treatment outcomes of MUP and MKP patients who had undergone therapy with immune checkpoint inhibitors (ICPI)
Thilo Gambichler   +4 more
doaj   +1 more source

Primary breast parenchyma melanoma: case report

open access: yesBrazilian Journal of Oncology, 2021
Introduction: Primary breast melanoma is a rare condition and most of cases are associated with melanoma overlying the skin of the breast or metastatic disease site.
Eduardo Doria   +5 more
doaj   +1 more source

SunSmart? Skin cancer knowledge and preventive behaviour in a British population representative sample [PDF]

open access: yes, 2005
The incidence of skin cancer has risen rapidly in the UK over the last 20 years, prompting public health organizations to try and raise awareness of the dangers of sun exposure and the need to practice sun-safe behaviour.
Miles, Anne   +11 more
core   +2 more sources

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

open access: yesVaccines, 2016
The immunosuppressive tumor microenvironment represents not only one of the key factors stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy.
Viktor Umansky   +3 more
doaj   +1 more source

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression

open access: yesExperimental and Molecular Medicine, 2023
Cancer: a drug combination for combating melanoma Drugs that target proteins involved in issuing stop and start commands to cancer-related genes help to sensitize melanoma cells to a widely used anti-cancer therapy, leading to tumor shrinkage in mice ...
Furong Zeng   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy